Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06439407
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-13
First Post:
2024-05-27
Brief Title:
Clinical Trial to Preliminarily Assess the Safety and Feasibility of SAT-014 a Software for Alleviating Symptoms of Trauma and Stress-related Disorders
Sponsor:
S-Alpha Therapeutics Inc
Organization:
S-Alpha Therapeutics Inc
Study Overview
Official Title:
An Open-label Randomized Controlled Exploratory Clinical Trial to Preliminarily Assess the Safety and Feasibility of SAT-014 a Software for Alleviating Symptoms of Trauma and Stress-related Disorders
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Failure to adapt to stress leads to functional impairments in various areas including social occupational educational and other significant domains necessitating therapeutic intervention Interventions through mobile app in the form of software can provide a new alternative for alleviating symptoms caused by psychological trauma by increasing accessibility to early intervention for trauma patients This study aims to preliminarily assess the safety and feasibility of a psychological traum intervention by developing SAT-014 to help patients with trauma and stress-related disorder continue effective treatment in a stable environment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None